-transparent.png){kind=logo}
The long-term effects of a tube extension to the terbutaline sulphate aerosol were studied in 23 patients. The trial was of open, randomised, cross-over design, and compared the ordinary actuator with the tube extension over two 3-week periods. Lung function before and after bronchodilator was measured at the start of the trial, at the treatment cross-over and at the end of the trial. The mean baseline FEV1 value obtained following 3 weeks of treatment with the tube extension was significantly greater (P less than 0.05) than that following treatment with the ordinary actuator. Treatment with the latter, however, produced significantly greater FEV1 values than at the start of the trial (P less than 0.05). At home, the patients recorded symptoms daily, as well as PEF each morning and evening. With the tube extension, the increase in PEF was significantly larger (P less than 0.05) than with the ordinary actuator. There were no differences with regard to symptom score.
K E Langaker, and
K G Hidinger
January 1984,
Revue de pneumologie clinique,
K E Langaker, and
K G Hidinger
January 1977,
Journal of clinical pharmacology,
K E Langaker, and
K G Hidinger
May 1993,
Chest,
K E Langaker, and
K G Hidinger
January 1992,
Anaesthesia,
K E Langaker, and
K G Hidinger
January 1983,
Polskie Archiwum Medycyny Wewnetrznej,
K E Langaker, and
K G Hidinger
July 1976,
The Journal of allergy and clinical immunology,
K E Langaker, and
K G Hidinger
August 1980,
Chest,
K E Langaker, and
K G Hidinger
May 2016,
Ugeskrift for laeger,
K E Langaker, and
K G Hidinger
April 1983,
International journal of clinical pharmacology, therapy, and toxicology,
